XML 55 R40.htm IDEA: XBRL DOCUMENT v3.25.1
Related Party Transactions (Tables)
12 Months Ended
Dec. 31, 2024
Related Party Transactions  
Schedule of common stock sold to related parties

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

Number of

​

Number of

    

Number of

​

Aggregate

​

​

​

Shares of

​

Pre-Funded

​

Common

​

Purchase

​

    

Common Stock

    

Warrants

    

Warrants

    

Price

OrbiMed Advisors LLC (1)

​

​

—

​

​

1,444,085

​

​

1,397,684

​

$

2,499,856

Puissance Capital Management (2)

​

​

866,451

​

​

—

​

​

838,610

​

​

1,500,000

Richard A. Miller, M.D. (3)

​

​

577,634

​

​

—

​

​

559,073

​

​

1,000,000

William B. Jones, Ph.D. (4)

​

​

20,001

​

​

—

​

​

19,358

​

​

34,624

​

(2)Peter Thompson, M.D., a member of our Board of Directors since November 2014, is a Member of OrbiMed Advisors, LLC.
(3)Ted Wang, Ph.D., a Co-Founder, General Manager and Director of Angel Pharmaceuticals, of which the Company holds a 49.7% ownership interest, is the founder of Puissance Capital Management.
(4)Richard A. Miller, M.D. is the Company’s President, Chief Executive Officer and Chairman of the Board.
(5)William B. Jones, Ph.D. is the Company’s Senior Vice President, Pharmaceutical Development.